Caris Life Sciences Inc.

Last updated September 27, 2026

Organization details

Legal name
Caris Life Sciences Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
8071 — Services-Medical Laboratories
Jurisdiction of incorporation
Texas
Headquarters city
Irving
Headquarters state / province
Texas
Headquarters country
United States
Fiscal year end
December
Ticker symbol
CAI
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0002019410
EIN
85-2077369

Board of directors

Director election results

Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

3 of this board's directors also sit on 3 other boards. 2 are in the same sector.

Network of Caris Life Sciences Inc.'s board connections 10x Genomics Inc. 10x Genomics Inc. Biogen Inc. Biogen Inc. Exelixis Inc. Exelixis Inc. George Poste George Poste Joseph E. Gilliam Joseph E. Gilliam Lloyd Minor Lloyd Minor Caris Life Sciences Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$1,491,538
2 purchases by 2 insiders
Sold, last 12 months
$28,859,363
7 sales by 4 insiders
Date Insider Transaction Shares Price Value
Sep 22, 2026 Denton John Russel Officer (See Remarks) Open-market sale −7,500 $31.82 $238,650
Sep 17, 2026 Brian J. Brille Director, Officer (See Remarks) Option exercise +400,000 $2.44 $976,000
Sep 17, 2026 Brian J. Brille Director, Officer (See Remarks) Open-market sale −400,000 $30.33 $12,132,000
Sep 4, 2026 Spetzler David Baxley Officer (President) Option exercise +250,000 $2.44 $610,000
Sep 4, 2026 Spetzler David Baxley Officer (President) Open-market sale −119,212 $24.76 $2,951,689
Sep 3, 2026 Spetzler David Baxley Officer (President) Option exercise +1,000,000 $2.44 $2,440,000
Sep 3, 2026 Spetzler David Baxley Officer (President) Open-market sale −393,100 $24.76 $9,733,156
Sep 3, 2026 Spetzler David Baxley Officer (President) Open-market sale −84,900 $25.32 $2,149,668
Aug 14, 2026 Peter M. Castleman Director Grant or award +13,192 — —
Aug 14, 2026 Jon Halbert Director Grant or award +13,192 — —
Aug 14, 2026 Laura I. Johansen Director Grant or award +13,192 — —
Aug 14, 2026 T. Danny Phillips Director Grant or award +13,192 — —
Aug 14, 2026 Joseph E. Gilliam Director Grant or award +13,192 — —
Aug 14, 2026 Jeff L. Vacirca Director Grant or award +13,192 — —
Aug 14, 2026 Lloyd Minor Director Grant or award +13,192 — —

Organizations in the same sector, closest in location and size first.

Questions about Caris Life Sciences Inc.

How many directors are on Caris Life Sciences Inc.'s board?

Caris Life Sciences Inc.'s board has 12 directors: Brian J. Brille, David D. Halbert, David Paul Fredrickson, George Poste, Jeff L. Vacirca, Jon Halbert, Jonathan Kenneth Charles Knowles, Joseph E. Gilliam, Laura I. Johansen, Lloyd Minor and 2 others.

Are Caris Life Sciences Inc. insiders buying or selling shares?

Over the last 12 months, Caris Life Sciences Inc. insiders bought $1.5 million of shares in 2 purchases and sold $28.9 million of shares in 7 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="caris-life-sciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.